トランプが投与されたリジェネロン社の抗体カクテル1億5千万円超: ずくなしの冷や水

2020年10月10日

トランプが投与されたリジェネロン社の抗体カクテル1億5千万円超

Eric Feigl-Ding@DrEricDing氏の2020/10/8のツイート
"As far as we know, the President is the only person in the world to have received this combination of treatments."

NYT also estimates it costs ~ $1.5 million for the Regeneron antibody cocktail.

・・・・・

リジェネロン社の抗体カクテル
150万ドル=1億5千万円超

npr October 6, 20208:38 PM ET
Cutting-Edge COVID-19 Care For Trump, Not Available For Regular Folks
Like hundreds of thousands of Americans who have been hospitalized with the coronavirus, President Trump is recovering at home after being discharged. Unlike most Americans, his home is equipped with a medical unit, where he will receive around-the-clock medical care from a team of physicians and nurses.

And the differences between his treatment and many people's don't stop there. The President has received cutting-edge care and VIP treatment since his diagnosis with COVID-19 last week, including a combination of treatments that would not have been available to most Americans early in the progression of the illness.

"The President received experimental therapies that no one has access to," says Leana Wen, an emergency physician and public health professor at George Washington University. "As far as we know, the President is the only person in the world to have received this combination of treatments," she says.

Since his diagnosis, Trump has received these key interventions: supplemental oxygen, steroids, an experimental antibody cocktail, and the antiviral medication remdesivir.

Part of the treatment was standard, says Dr. William Schaffner, a professor of infectious diseases at the Vanderbilt University Medical Center in Nashville, Tennessee. "I think most good hospitals would provide the basic structure of that sort of treatment to their patients across the country."

But, he adds, treatment with the antibody cocktail made by Regeneron is the one exception − that's still in clinical trials and has not been granted emergency use authorization by the federal government.

"Those monoclonal antibodies... would not have been available to others," Schaffner says.

ワールド
2020年10月9日3:55 午前8時間前更新
米リジェネロンの抗体療法、トランプ氏に効果か=ファウチ氏
[ニューヨーク 8日 ロイター] - 米国立アレルギー感染症研究所のファウチ所長は8日、新型コロナウイルスに感染したトランプ米大統領の経過について、米リジェネロン・ファーマシューティカルズREGN.Oが開発中の「抗体カクテル」に効果があった可能性があるとの見解を示した。
ファウチ所長はMSNBCのインタビューに対し、「(リジェネロンの抗体カクテルで)トランプ氏の容体が改善した可能性は十分にある」と述べた。
その上で、抗体療法の緊急使用許可承認について米食品医薬品局(FDA)が検証すると述べた。
ファウチ氏はこのほか、新型ウイルス感染症は季節性インフルエンザよりもはるかに危険と警告した。

Maggie Haberman@maggieNYT氏の2020/10/10のツイート
The president said the dex he was taking was to keep the "swelling" of the lungs down. He said he doesn't take it anymore. Asked if he's still taking medicine, he says "pretty much nothing." Unclear when this was taped.

Eric Feigl-Ding@DrEricDing氏の2020/10/10のツイート
New−Trump now confirms he has swelling in his lungs, and hence the dexamethasone. This has never been confirmed before, not even by Dr Conley. Trump had a pretty serious #COVID19, no doubt about it now. But is VERY unusual to go from initial symptoms to hospitalization in 1 day.

Eric Feigl-Ding@DrEricDing氏の2020/10/10のツイート
2) it is unusual because the time course from symptoms to shortness of breath/ hospitalization is usually 6-7 days after first fever/cough symptom onset. Thus, Thursday first reported illness to Friday night hospitalization is INSANELY fast.

クリックで拡大画像
dyspnoea:呼吸困難、sepsis:敗血症、ARDS:急性呼吸不全、systemic corticosteroids:全身性コルチコステロイド、costeroids:副腎皮質ステロイド薬、invasive ventilation:侵襲的換気(ECMOの使用だと思います)
posted by ZUKUNASHI at 10:32| Comment(0) | Covid19
この記事へのコメント
コメントを書く
お名前: [必須入力]

メールアドレス: [必須入力]

ホームページアドレス:

コメント: [必須入力]

※ブログオーナーが承認したコメントのみ表示されます。